Effect of angiotensin-II on renal Na+/H+ exchanger-NHE3 and NHE2  by Dixit, Mehul P et al.
www.bba-direct.com
Biochimica et Biophysica Acta 1664 (2004) 38–44Effect of angiotensin-II on renal Na+/H+ exchanger-NHE3 and NHE2
Mehul P. Dixit*,1, Liping Xu1, Hua Xu, Liqun Bai, James F. Collins, Fayez K. Ghishan
Department of Pediatrics and Physiology, Steele Memorial Children’s Research Center, University of Arizona Health Sciences Center,
1501 N. Campbell Avenue, Tucson, AZ 85724, USAReceived 24 October 2003; received in revised form 22 March 2004; accepted 25 March 2004
Available online 26 April 2004Abstract
The purpose of the present study was to determine the effect of angiotensin II (A-II) on membrane expression of Na+/H+ exchange
isoforms NHE3 and NHE2 in the rat renal cortex. A-II (500 ng/kg per min) was chronically infused into the Sprague–Dawley rats by
miniosmotic pump for 7 days. Arterial pressure and circulating plasma A-II level were significantly increased in A-II rats as compared to
control rats. pH-dependent uptake of 22Na+ study in the presence of 50 AM HOE-694 revealed that Na+ uptake mediated by NHE3 was
increased f 88% in the brush border membrane from renal cortex of A-II-treated rats. Western blotting showed that A-II increased NHE3
immunoreactive protein levels in the brush border membrane of the proximal tubules by 31%. Northern blotting revealed that A-II increased
NHE3 mRNA abundance in the renal cortex by 42%. A-II treatment did not alter brush border NHE2 protein abundance in the renal proximal
tubules. In conclusion, chronic A-II treatment increases NHE3-mediated Na+ uptake by stimulating NHE3 mRNA and protein content.
D 2004 Elsevier B.V. All rights reserved.Keywords: Na+/H+ exchange; Proximal tubule; Kidney; Sodium uptake1. Introduction
The sodium-hydrogen exchangers (NHEs) are plasma
membrane-bound proteins that mediate the movement of
extracellular Na+ into cells in exchange for intracellular H+.
Eight NHE isoforms have been identified from mammalian
cells [1]. Among them, five NHE isoforms (NHE1, NHE2,
NHE3, NHE4 and NHE8) have been described in the
kidney. NHE1 and NHE4 are located in the basolateral
membrane of the renal tubule, and NHE2, NHE3 and NHE8
are apical isoforms [1–3]. Specifically, NHE3 is expressed
in S1 and S2 segments of the proximal tubule and in the
cortical thick ascending limb of the loop of Henle [4–8].
NHE3 plays a significant role in Na+ and fluid reabsorption
in the proximal tubule. NHE3 null mice have reduced Na+
and HCO3
 reabsorption in the proximal tubule with urinary
Na+ and HCO3
 wasting [9].
Angiotensin II (A-II) is an essential hormone that exerts
pleiotropic actions in the renal proximal tubule including
modulation of transport [10,11], metabolism [12], and cell0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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1 These authors contributed equally to this work.proliferation [13]. A-II is a powerful vasoconstrictor and
strong mediator of intravascular volume regulation [14]. A-
II acts indirectly on the distal nephron through aldosterone
secretion by the adrenal glands, but it also acts directly on
the proximal tubule in regulating NaCl reabsorption [14].
The renal proximal tubule is the main site for renal water,
salt, and HCO3 resorption [5]. It is well established that A-
II increases renal Na+ and HCO3 reabsorption [15,16].
Studies from micropuncture and microperfusion also indi-
cated that proximal tubule Na+ and water transport on the
peritubular side was stimulated by physiological concen-
trations of A-II [17]. Moreover, studies have shown that A-
II stimulates Na+ uptake in isolated proximal tubule cells
through the amiloride-sensitive Na+/H+ exchanger, and this
activation can be inhibited by the receptor antagonist
saralasin [16]. Recently, study have shown that increased
abundance of NHE3 in thick ascending limb cells as well
as in proximal tubule brush border may contribute to
enhanced renal Na+ and HCO3 reabsorption in response
to A-II [18].
NHE2 and NHE3 have a more restricted tissue distri-
bution, being predominantly located in the apical mem-
brane of epithelia, and are highly expressed in the intestine
and in the kidney. They are thought to be involved in
bicarbonate, and water reabsorption [19]. However, the
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not completely understood.
Until now, the effect of A-II on NHE2-mediated Na+
reabsorption in the kidney remains unknown. To understand
the effect of A-II on renal sodium transport mediated by
NHE3 and NHE2 in the proximal tubule, we tested the A-II
infusion model and used this model to investigate molecular
mechanisms of prolonged A-II administration on renal
NHE3 and NHE2 expression. Our result showed that
prolonged A-II treatment increased apical NHE3-mediated
Na+ absorption, apical NHE3 protein and NHE3 mRNA
abundance. However, apical NHE2 transporter in the renal
cortex was not affected by A-II treatment based on Western
blotting analysis. The current findings suggest that the
increase in apical NHE3 activity is a reflection of increased
NHE3 gene expression in response to A-II.2. Materials and methods
2.1. Preparation of animals and tissues
Adult male Sprague–Dawley rats (Harlan, Madison, WI)
were housed separately in overhanging cages and main-
tained in a temperature, light and humidity controlled room.
Throughout the experiments, animals had free access to
water and standard rat chow (Ralson Purina, St. Louis, MO).
All animal work was approved by the University of Arizona
Institutional Animal Care and Use Committee. Rats (weigh-
ing 280–300 g; n = 28) were anesthetized with sodium
pentobarbital (50 mg/kg body wt; administered intraperito-
neally), and an osmotic minipump (model 2001; Alza, Palo
Alto, CA) was implanted subcutaneously at the dorsum of
the neck. Rats were randomly assigned to two experimental
groups. One group of 16 rats received A-II infusion (Sigma,
St. Louis, MO), at a rate of 130 ng/min (approximately 500
ng/kg per min), for a period of 7 days, while another group
of 12 rats received saline and served as controls. Preliminary
studies with 1, 2, 3 and 7 days of infusions were carried out
to determine duration of A-II infusion.
Several rats were maintained in metabolic cages, and
24-h urine and water intake were collected 1 day prior
to implantation of minipumps to establish the baseline
value and on days 4 and 7 of infusion. The concen-
trations of sodium and creatinine in urine samples were
measured by University of Arizona Animal Care Diag-
nostic Laboratory.
Systolic arterial BP was measured in conscious rats on
day 6 of infusion, using tail-cuff plethysmography (IITC
INC/Life Science Instruments, Model 179; Woodland Hills,
CA). Rats were killed by CO2 anesthesia followed by
cervical dislocation. Blood samples were collected into
chilled tubes containing EDTA. Plasma was separated and
stored at  80 jC until a plasma A-II concentration assay
was performed with an enzyme immunoassay kit (Spibio,
France). One renal cortex was excised, snap-frozen in liquidnitrogen, and stored at  80 jC until processing for mRNA
purification. The other renal cortex was used for brush
border membrane vesicle (BBMV) preparation on the day
of BBMV uptake or for Western blot analyses and was never
frozen.
2.2. BBMV preparation of rat renal cortex
BBMV were prepared from the renal cortex by the
MgCl2 precipitation technique as previously described
[20,21].
2.3. Uptake analysis of rat renal BBMV
pH-dependent uptake of radiolabeled sodium was mea-
sured by a rapid filtration technique as previously described
[20,22]. Protein was quantitated by a Bradford protein
assay. The final BBMV pellets were resuspended in either
preincubation buffer for no pH gradient condition [intracel-
lular pH (pHi) and extracellular pH (pH0) equal 7.5] [100
mM TMA-gluconate, 85 mM HEPES, 45mM Tris/HCl (pH
7.5)], or preincubation buffer with an outwardly directed pH
gradient (pHi 5.2, pH0 7.5) [100 mM TMA-gluconate, 90
mM MES, 40 mM HEPES/Tris (pH 5.2)], and placed at 25
jC for 1 h. Briefly, transport was initiated by adding 20 Al of
the final BBMV suspension to 80 Al incubation solution
[same as preincubation buffer (pH 7.5)], with the addition
of 31.25 ACi 22Na+/10 ml. Studies were performed in the
presence of 50 AM HOE-694, a specific NHE inhibitor,
which allows selective inhibition of NHE2 [inhibition
constant (Ki) = 5 AM in PS120 cells], without affecting
NHE3 (Ki= 650 AM in PS120 cells) [23]. HOE-694 [(3-
methylsulfonyl-4-piperidinobenzoyl) guanidine methanesul-
fonate] was kindly provided by Dr. H.J. Lang (Hoechst
Marion Roussel Pharmaceuticals, Frankfurt am Main, Ger-
many). The reactions were stopped after 10 s by adding 2
ml ice-cold stop solution (185 mM potassium-gluconate, 10
mM Tris, 16 mM HEPES, 0.1 mM amiloride). The vesicles
were immediately collected on a cellulose nitrate filter (0.45
Am pore size) and kept under suction while they were
washed with 5 ml ice-cold stop solution. The amount of
radioactive substrate remaining on the filter was determined
in a Beckman liquid scintillation counter, with ReadySafe
(Beckman, Fullerton, CA) as the liquid scintillant. Radio-
activity remaining on the filters after pipetting incubation
medium into the radioactive substrate in the absence of
vesicles was used as background, and was considered in all
calculations. Uptake values were determined by subtracting
the uptake levels with no pH gradient condition (pHi/
pH0 = 7.5/7.5) from those with an outwardly directed pH
gradient (pHi/pH0 = 5.2/7.5). All values are expressed as
pmol of sodium uptake per mg of vesicular protein in 10 s.
Three repetitions were performed on membrane vesicle
preparations from three different groups of animals from
both A-II-infused and saline-infused rats and at least three
rats for each group.
Fig. 1. Effect of A-II infusion on water intake (A), urine output (B). Rats
were infused with saline or A-II (500 ng/kg per min) by osmotic minipump
for 7 days. Water intake, urine output were measured 1 day before pump
implantation, at 4 and 7 days of infusion. Values are meanF S.E. of six rats.
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and NHE3-specific antiserum
Protein (20 Ag) was placed in a twofold excess of
Laemmli solubilization buffer plus 2 mM h-mercaptoetha-
nol (h-ME), boiled for 5 min and placed on ice. Protein
samples were fractionated by 7.5% SDS polyacrylamide gel
electrophoresis (SDS/PAGE), and transferred onto nitrocel-
lulose membranes. Blots were reacted with 1:4000 dilutions
of rabbit NHE3-specific polyclonal antibody as previously
described [24,25]. This antibody was raised against a fusion
protein encompassing amino acids 699–831 from the
COOH-terminal portion of the NHE3 protein generated by
baculovirus-mediated expression in Sf9 cells [26]. Addi-
tionally, some blots were reacted with 1:500 dilutions of
NHE2-specific antiserum as previously described [26]. The
anti-mouse/anti-rabbit secondary antibody (40 mU/ml;
Boehringer Mannheim GmbH, Germany) was used with
the reagent for chemiluminescent detection (Boehringer
Mannheim). Membranes were stripped and subsequently
reacted with h-actin antiserum (Sigma) at 1:5000 dilution.
NHE3- or NHE2-specific band intensities were determined
by densitometric analysis [utilizing GS-700 Imaging Den-
sitometer and Quantity One software (Bio-Rad, Hercules,
CA)] and were normalized for h-actin band intensities on
the same blot. Experiments were repeated three times with
protein samples isolated from different groups of animals
from both A-II-infused and saline-infused rats.
2.5. RNA purification and Northern blot analyses of rat
renal cortex
mRNA was isolated from the renal cortex, utilizing the
Fast-Track mRNA purification kit (Invitrogen, Carlsbad,
CA). Northern blots were carried out as previously de-
scribed, using 5 Ag mRNA/lane [24,25]. Rat NHE3-
specific cDNA radiolabeled probes (DraI- and KpnI-
digested fragment) [24] were used for hybridization.
High-stringency washes were performed at 65 jC with
0.1 SSC–0.1% SDS. Northern blots were subsequently
stripped and reprobed with 1B15-specific cDNA probes
(1B15 encodes rat cyclophilin [2]), which were used as
internal standards for quantitating NHE3 mRNA expres-
sion. Blots were exposed to phosphor imaging screens,
and band intensities were determined with Quantity One
Software (FX Molecular Imager; Bio-Rad). Experiments
were repeated three times with mRNA samples isolated
from different groups of animals from both A-II-infused
and saline-infused rats.
2.6. Statistical analyses
The experimental data are expressed as meansF S.E.
They were analyzed by ANOVA (StatView 5.0.1 version;
SAS Institute, Cary, NC). P values of < 0.05 indicate
statistical significance.
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3.1. Blood pressure and plasma A-II levels
Blood pressure and plasma A-II levels were measured in
some rats in this current study. On day 6 of infusion, systolic
BP was significantly elevated in the A-II-treated rats, com-
pared to controls (190F 4 mm Hg in A-II treated rats, versus
120F 3 mm Hg in control rats; n = 6 rats, P < 0.001).
On day 7 of infusion, circulating plasma A-II levels were
markedly increased in the A-II group, compared to controls
(53.0F 7.7 fmol/ml plasma in A-II treated rats, versus
8.1F1.5 fmol/ml plasma in control rats; n = 5 rats, P < 0.02).
3.2. Water intake, urine output and Na+ excretion
Water intake for the two groups was identical at the
initiation of the study (A-II, 35.0F 2.2 ml/day, n = 6 rats;
control, 40.0F 6.3 ml/day, n = 5 rats, P= 0.4). On day 4 of
Fig. 2. Na+ uptake analysis of rat renal cortical BBMV. BBM vesicles were
prepared from groups of rats treated with A-II or saline. pH-dependent
uptake of 22Na+ were performed in the presence of 50 AMHOE-694. Values
are meanF S.E.; number of replicates = 3. *P < 0.05.
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was significantly higher than that for the saline-treated rats
(98.0F 7.0 ml/day in A-II group, versus 41.0F 1.5 ml/day
in controls, P= 0.0001). On day 7 of infusion, the average
water intake for the A-II-treated rats was significantly higher
than that for the saline-treated ones (82.0F 5.0 ml/day in A-
II group, versus 37.0F 1.9 ml/day in controls; P= 0.0001)
(Fig. 1A).Fig. 3. Western blot analysis of NHE2 protein in rat renal cortical BBMV.
Panel A shows one typical Western blot experiment. Western blots were
reacted with NHE2-specific and h-actin-specific antiserum. The band at 85
kDa is NHE2 and the band at 42 kDa is h-actin. Panel B shows quantitative
data from NHE2 Western blot experiments. Data are presented as a ratio of
NHE2 to h-actin protein levels. Values are meanF S.E.; number of
replicates = 3.Urine output for the two groups was identical at the
initiation of the study (A-II, 12.0F 1.6 ml/day, n = 6 rats;
control, 11.0F 1.0 ml/day, n= 5 rats, P= 0.6). On day 4 of
infusion, the average urine output for the A-II treated rats
was significantly higher than that for the saline-treated ones
(73.0F 8.7 ml/day in A-II group, versus 18.0F 1.3 ml/day
in controls, P= 0.0003). On day 7 of infusion, the average
urine output for the A-II-treated rats was significantly higher
than that for the saline-treated ones (57.0F 5.2 ml/day in A-
II group, versus 18.0F 1.3 ml/day in controls, P= 0.0001)
(Fig. 1B).
Urine sodium excretion was normalized to urine creatinine
concentration. Urine sodium/creatinine ratio for the two
groups was identical at the initiation of the study (A-II, 3.1F
0.2, n = 6 rats; control, 2.6F 0.4, n = 5 rats, P= 0.3). On days
4 and 7 of infusion, the average urine sodium/creatinine ratio
shows no significant difference between A-II treated and con-
trol rats (on day 4 of infusion, 3.2F 0.2 in A-II group, versus
2.7F 0.2 in controls, P= 0.1; on day 7 of infusion, 3.5F 0.3
in A-II group, versus 2.8F 0.2 in controls, P= 0.07).
3.3. A-II increases brush border membrane NHE3 activity
in the rat renal cortex
BBMVwere purified from the rat kidney cortex in A-II or
saline-infused groups. Total BBMV pH-dependent Na+ up-
take was performed in the absence of HOE-694, reflectingFig. 4. Western blot analysis of NHE3 protein in rat renal cortical BBMV.
Panel A shows one typical Western blot experiment. Western blots were
reacted with NHE3-specific and h-actin-specific antiserum. The band at 85
kDa is NHE3 and the band at 42 kDa is h-actin. Panel B shows quantitative
data from NHE3 Western blot experiments. Data are presented as a ratio of
NHE3 to h-actin protein levels. Values are meanF S.E.; number of
replicates = 3; *P < 0.05.
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NHEs. The total pH-dependent BBMV Na+ uptake was not
significantly altered by A-II treatment (data not shown), but
HOE-694-insensitive Na+ uptake was remarkably increased.
As shown in Fig. 2, NHE3-mediated Na+ uptake performed
in the presence of 50 AM HOE-694 was increased f 88%
with A-II treatment (2330.7F 267.3 pmol/mg protein/10 s in
A-II groups; versus 1241.4F 131.6 in control groups; n = 3,
P= 0.005).
3.4. Brush border membrane NHE2 protein abundance in
the rat renal cortex was unchanged in response to A-II
treatment
Western blot analyses with NHE2 antiserum showed
specific recognition of an 85 kDa protein and A-II infusion
didn’t significantly change this immunoreactive NHE2
protein level, compared with controls (0.46F 0.01 densito-
metric units in A-II groups, versus 0.5F 0.06 in control
groups; n = 3, P= 0.55) (Fig. 3).
3.5. A-II increases brush border membrane NHE3 protein
abundance in the rat renal cortex
Western blot analyses with NHE3 antiserum showed
specific recognition of an 85 kDa protein and A-II infusionFig. 5. Northern blot analysis of NHE3mRNA expression in rat renal cortex.
Panel A shows one typical Northern blot experiment. Northern blots were
probed with NHE3-specific and 1B15-specific probes. The hybridization
signal at 4.4 kilobase pairs (kb) represents rat NHE3, and hybridization signal
at 1.0 kb represents 1B15. Panel B shows quantitative data from NHE3
Northern blot experiments. Data are presented as a ratio of NHE3 to 1B15
mRNA levels. Values are meanF S.E.; number of replicates = 3. *P < 0.05.increased the immunoreactive NHE3 protein band by 31%,
compared with controls (1.23F 0.03 densitometric units in
A-II groups, versus 0.94F 0.02 in controls; n= 3, P= 0.02)
(Fig. 4).
3.6. A-II increases NHE3 mRNA abundance in the rat renal
cortex
Northern blots were hybridized with NHE3-specific and
1B15-specific radiolabeled probes. As shown in Fig. 5,
NHE3 mRNA abundance was increased by 42% after A-II
administration, compared to controls (3.94F 0.13 densito-
metric units in A-II groups, versus 2.77F 0.21 in controls;
n = 3, P= 0.009).4. Discussion
The present study was designed to examine the effects of
chronic A-II on Na+/H+ exchange isoform 2 and isoform 3.
In the current study, we demonstrate that long-term A-II
treatment increases apical NHE3-mediated Na+ absorption,
apical NHE3 protein abundance and NHE3 mRNA abun-
dance. This increase in renal apical NHE3 activity might be
partially due to the activation of NHE3 gene expression. We
also demonstrate that the apical NHE2 transporter protein
abundance is not affected by A-II treatment.
The present study utilized a previously established model
of A-II-induced hypertension [27–31] to study the role of
long-term A-II treatment on renal NHE2 and NHE3 regu-
lation. In this study, we observed that A-II infusion signif-
icantly increases the systolic BP and plasma A-II levels,
which was in agreement with other researchers [32]. The
infusion dose of 500 ng min 1 kg 1 results in A-II plasma
levels very similar to those found in the two-kidney one-clip
Goldblatt model, which is widely used for renovascular
hypertension studies [28].
In our study, A-II infusion significantly increased water
intake above control levels, which is consistent with previ-
ous reports that circulating A-II can act on specific brain
receptors to stimulate thirst [33]. We observed a large
increase in the excretion of water, but no change in Na+
excretion.
It has been shown that both NHE2 and NHE3 contribute
to Na+/H+ exchange in the apical membrane of renal
proximal tubule [34]. BBMV pH-dependent Na+ uptake
results suggest that HOE-694-sensitive transporters might
have a counter-regulatory effect. Since NHE2 is a HOE-
694-sensitive isoform (IC50 = 5 AM in PS120 cells) [23], we
aimed to determine if the BBMV NHE2 protein is altered
by A-II treatment. Western blot analysis of NHE2 showed
that A-II treatment did not change BBMV NHE2 protein
abundance; suggesting HOE-694-sensitive NHE isoforms
other than NHE2 are involved. HOE-694 in 50 AM con-
centration is known to selectively inhibit NHE2 activity,
therefore, Na+ uptake with 50 AM HOE-694 represents
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the presence of 50 AM HOE-694 A-II increased pH-depen-
dent Na+ uptake by 88%.
To determine if the increase of HOE-694-insensitive Na+
uptake is due to the increase in the apical NHE3 transporter,
Western blotting was performed. Quantitation of bands from
immunoblots with NHE3 antiserum showed that A-II infu-
sion significantly increased NHE3 protein abundance in the
brush border of the proximal tubules. This result is in
agreement with a recent study [18].
In the our study, NHE3 functional activity increased by
88%, while BBMV NHE3 immunoblotting analysis
showed a 31% increase in protein abundance. A possible
explanation for this discrepancy may be that there can be
post-translational modulation of NHE3 protein, such as
phosphorylation/dephosphorylation regulation [36]. This
modulated NHE3 protein cannot be detected by the
NHE3 antibody used in our experiments.
To address if the NHE3 protein increase is due to an
increase in NHE3 gene expression, Northern blot studies
were performed. Our study shows a small but consistent and
statistically significant increase in mRNA abundance. This
change in mRNA expression parallels the change in immu-
noreactive protein expression. These results suggest that the
increase in NHE3 protein after A-II treatment is likely due
to increase in NHE3 gene transcription.
A recent study showed that the BBMV NHE3 protein
abundance increased in response to A-II treatment through
subcellular redistribution of NHE3 or differential protein–
protein interaction [18]. The total NHE3 protein abundance
was not altered. In our study, we did not examine total
NHE3 protein abundance in the renal cortex. We studied the
increase in BBMV NHE3 function that was due to increase
in NHE3 mRNA abundance. This suggests that transcrip-
tional regulation may be involved. The discrepancy between
these two studies may be ascribed to the differences in rat
species (Sprague–Dawley rats versus Munich–Wistar rats),
A-II infusion dose (500 versus 200 ng min 1 kg 1),
feeding style (free access water/food versus restricted ac-
cess), and other intangible factors.
Renal tubular effects of A-II are believed to be mediated
by A-II type 1 (AT1)-receptor. Treatment with the AT1-
receptor antagonist, candesartan, decreases the abundance of
NHE3 in the brush border membrane from rat kidney
proximal tubule [37]. This indicates that A-II regulation of
NHE3 is likely to be mediated by the AT1 receptor.
However, other researchers have shown that in A-II type
1a (AT1a) receptor knockout mice maintained on a low-
NaCl diet, NHE3 protein abundance shows no change as
compared to wild-type [38]. This raises the possibility that
the expression of NHE3 may be independent on AT1a
receptor. In our study, whether or not the effect of A-II on
NHE3 activity was mediated by AT1 receptor was not
assessed.
In summary, we have shown that long-term A-II infusion
induces activity of apical NHE3 transporter in the proximaltubule through stimulating NHE3 mRNA and protein con-
tent. A-II treatment has no effect on renal NHE2 transporter
protein abundance.Acknowledgements
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